Cargando…

Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets

The identification of cancer-specific vulnerability genes is one of the most promising approaches for developing more effective and less toxic cancer treatments. Cancer genomes exhibit thousands of changes in DNA methylation and gene expression, with the vast majority likely to be passenger changes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwalbe, Edward C., H, Lalchungnunga, Lafta, Fadhel, Barrow, Timothy M., Strathdee, Gordon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376645/ https://www.ncbi.nlm.nih.gov/pubmed/34230614 http://dx.doi.org/10.1038/s41388-021-01923-1

Ejemplares similares

Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia
por: Gabriel, Alem S, et al.
Publicado: (2015)

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma
por: Lalchungnunga, H., et al.
Publicado: (2022)

Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia
por: Barrow, Timothy M., et al.
Publicado: (2020)

Identification of TIAM1 as a Potential Synthetic-Lethal-like Gene in a Defined Subset of Hepatocellular Carcinoma
por: Permtermsin, Chalermsin, et al.
Publicado: (2023)

Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities
por: Hijazo‐Pechero, Sara, et al.
Publicado: (2023)

Immunological parameters of recurrent miscarriages among women in Thi-Qar province
por: Hamadi, Ghaneemah Malik, et al.
Publicado: (2022)

Metabolic subtype reveals potential therapeutic vulnerability in acute promyelocytic leukaemia
por: Sung, Ji‐Yong, et al.
Publicado: (2022)

A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
por: McNicholas, Michael, et al.
Publicado: (2023)

Differential Regional and Subtype-Specific Vulnerability of Enteric Neurons to Mitochondrial Dysfunction
por: Viader, Andreu, et al.
Publicado: (2011)

Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
por: Farin, Henner F., et al.
Publicado: (2023)

Integrative subspace clustering by common and specific decomposition for applications on cancer subtype identification
por: Guo, Yin, et al.
Publicado: (2019)

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
por: Rabasco Meneghetti, Asier, et al.
Publicado: (2022)

MEDB-43. Development of a bioinformatics pipeline for identification of differential DNA methylation events associated with medulloblastoma relapse
por: Kui, Christopher, et al.
Publicado: (2022)

Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
por: Lehmann, Brian D., et al.
Publicado: (2021)

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
por: Ding, Ren-Bo, et al.
Publicado: (2021)

ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer
por: Zhou, Yuzhen, et al.
Publicado: (2023)

Chromosomal neighbourhoods allow identification of organ specific changes in gene expression
por: Das Roy, Rishi, et al.
Publicado: (2021)

Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities
por: Eddy, Kevinn, et al.
Publicado: (2021)

DIPG-35. IDENTIFYING DRIVER-SPECIFIC VULNERABILITIES IN PAEDIATRIC HIGH GRADE GLIOMA SUBTYPES
por: De Cola, Antonella, et al.
Publicado: (2023)

Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
por: Rontogianni, Stamatia, et al.
Publicado: (2019)

Antigen 85B peptidomic analysis allows species-specific mycobacterial identification
por: Zhang, Wei, et al.
Publicado: (2018)

Alternative lengthening of telomeres is mechanistically linked to potential therapeutic vulnerability in the stem‐like subtype of gastric cancer
por: Sung, Ji‐Yong, et al.
Publicado: (2021)

Somatic mutation subtypes of lung adenocarcinoma in East Asian reveal divergent biological characteristics and therapeutic vulnerabilities
por: Choong, Wai-Kok, et al.
Publicado: (2021)

Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2022)

Integrated morphologic analysis for the identification and characterization of disease subtypes
por: Cooper, Lee A D, et al.
Publicado: (2012)

Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach
por: Zhang, Di, et al.
Publicado: (2015)

Identification of Breast Cancer Subtype-Specific Biomarkers by Integrating Copy Number Alterations and Gene Expression Profiles
por: Cava, Claudia, et al.
Publicado: (2021)

An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
por: Pan, Chun‐Hao, et al.
Publicado: (2020)

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
por: Cosgrove, Nicola, et al.
Publicado: (2022)

Segment-Specific Neuronal Subtype Specification by the Integration of Anteroposterior and Temporal Cues
por: Karlsson, Daniel, et al.
Publicado: (2010)

Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability
por: Drexler, Richard, et al.
Publicado: (2023)

Integrating Soluble Biomarkers and Imaging Technologies in the Identification of Vulnerable Atherosclerotic Patients
por: Páramo, José A., et al.
Publicado: (2007)

Analysis of retrotransposon subfamily DNA methylation reveals novel early epigenetic changes in chronic lymphocytic leukemia
por: Barrow, Timothy M., et al.
Publicado: (2020)

Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential
por: Carino, Adriana, et al.
Publicado: (2021)

Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer
por: Thaiparambil, Jose, et al.
Publicado: (2022)

Integrated regulatory models for inference of subtype‐specific susceptibilities in glioblastoma
por: Liu, Yunpeng, et al.
Publicado: (2020)

Identification of Subtype-Specific Metastasis-Related Genetic Signatures in Sarcoma
por: Li, Ya-Ling, et al.
Publicado: (2020)

Identification of region-specific astrocyte subtypes at single cell resolution
por: Batiuk, Mykhailo Y., et al.
Publicado: (2020)

A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma
por: Dela Cruz, Filemon S., et al.
Publicado: (2016)

Quantification of mixed chimerism allows early therapeutic interventions
por: Merzoni, Jóice, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_te4bel3oh2a2kagbemoj6sf9vp